Are Cineworld shares going to zero?

Shares of Cineworld collapsed this week after the courts ruled against it in the lawsuit with Cineplex. But could this bankrupt the company?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors in Cineworld (LSE:CINE) are understandably horrified this week after the shares collapsed by almost 40% on Wednesday. The stock price has since recovered a small amount of this decline. But even with that, the 12-month return generated by these shares now stands at a disappointing -50%. What happened? Is this the start of the company’s ultimate demise? Or is now the perfect time to start buying? Let’s explore.

The devastating power of a lawsuit

To understand what happened this week, I need to go back to December 2019. Cineworld had just signed a $2.8bn acquisition deal to purchase Cineplex, a Canadian cinema chain. The deal was supposed to close by mid-2020, and it would make Cineworld the largest cinema company on the planet.

At the time, this deal sounded fantastic. It once again allowed the company to expand its international operations, delivering even more growth to investors. Yet, as many already know, this deal never happened. That’s because, in June 2020, management announced the agreement was off, leading to an onslaught of legal proceedings.

Cineworld claimed that Cineplex had breached the terms of the signed contract. Without knowing the exact details of the agreement, it’s hard to say if the claims are true. But, if I were to speculate, I think the likely cause for the sudden pull-out had more to do with the global pandemic that decimated the business, which was now in full save-money mode.

It seems the courts agree with my view because, on Wednesday, the Ontario Superior Court of Justice ruled in favour of Cineplex. It awarded the firm CA$1.23bn while simultaneously dismissing Cineworld’s counterclaims. That’s obviously not the outcome Cineworld’s investors were expecting, and Cineworld shares crashed as a consequence. Management unsurprisingly disagrees with the verdict and has begun appeal proceedings. But how long this will take or whether the ruling will be changed is entirely unknown at this stage.

What happens to Cineworld and its shares now?

For the moment, nothing really changes. At least not yet. While the appeal proceedings continue, Cineworld has stated they won’t be making any payments to Cineplex. If the appeal is successful, then Cineworld shares will most likely surge to reverse this week’s downfall. But what if the appeal efforts fail and Cineworld has to cough up?

I’ve been following this company throughout the pandemic. And before this week, things started to look like they were finally heading in the right direction. In the latest earnings report, the success of many delayed blockbuster titles resulted in October UK revenues growing by 27% versus pre-pandemic levels. Meanwhile, international performance has also been catching up and is now close to returning to 2019 levels as well.

But after taking on considerable debt to stay afloat in early 2020, most of the profits are being gobbled up by interest payments on loans. And with only $437m of cash on its balance sheet, Cineworld will likely once again have to load up on even more debt to pay the Cineplex fine. Needless to say, this is a serious problem. And one that could lead to insolvency.

Management still has several levers at its disposal to raise capital through equity or property sales. So, it’s still possible for the company to make a comeback. However, with the current state of the balance sheet and some significant restructuring required, I personally wouldn’t touch Cineworld shares with a 10-foot pole.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »